Barbara Adamo

发表

Hormone receptor-positive early breast cancer in young women: A comprehensive review.

M. Bellet, F. Brasó-Maristany, Benjamín Walbaum, 2024, Cancer treatment reviews.

Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer

C. Perou, B. González-Farré, P. Galván, 2024, Scientific reports.

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study

N. Viñolas, P. Galván, N. Basté, 2023, Cancer Immunology, Immunotherapy.